This project focuses on the continued development of a resorbable osteoconductive bone cement for maxillofacial bone repair. A prototype two-part polymer formulation has been shown to be moldable for 15-20 minutes, to cure with a temperature rise of no greater than 5 degrees C, to set-up in situ to a material of compressive modulus and stress failure compatible with reported requirements, and to degrade slowly in aqueous environments. The present project focuses on optimizing the prototype formulation with the objectives to increase initial plasticity, reconcile the rate of cement degradation with bone growth, and maintain dimensional stability. Formulations will be tested for degradation in vitro and, then, for both degradation and biocompatibility in vivo via subcutaneous implantation in rats. Further developmental work will pursue the incorporation of a selected osteoinductive bone regeneration protein into the bone cement. In vitro studies will confirm protein integrity and in vivo studies will evaluate the effects of the protein/cement on the bone repair process itself.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44DE008880-02
Application #
2130208
Study Section
Special Emphasis Panel (SRC (05))
Project Start
1992-09-30
Project End
1994-09-29
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Cambridge Scientific, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Gresser, J D; Hsu, S H; Nagaoka, H et al. (1995) Analysis of a vinyl pyrrolidone/poly(propylene fumarate) resorbable bone cement. J Biomed Mater Res 29:1241-7